GlaxoSmithKline PLC Director/PDMR Shareholding (1100C)
05 Febbraio 2020 - 5:15PM
UK Regulatory
TIDMGSK
RNS Number : 1100C
GlaxoSmithKline PLC
05 February 2020
GlaxoSmithKline plc (the 'Company')
Transaction notification
1. Details of PDMR/person closely associated with them
('PCA')
==== ==============================================================================================
a) Name Sir Jonathan Symonds
==== ======================================== ====================================================
b) Position/status Non-Executive Chairman
==== ======================================== ====================================================
c) Initial notification/ Initial notification
amendment
==== ======================================== ====================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
==== ==============================================================================================
a) Name GlaxoSmithKline plc
==== ======================================== ====================================================
b) LEI 5493000HZTVUYLO1D793
==== ======================================== ====================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
==== ==============================================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
==== ======================================== ====================================================
b) Nature of the Acquisition of notional Ordinary Shares
transaction under the share allocation arrangements
for Non-Executive Directors for the period
of service from 1 October 2019 to 31 December
2019
==== ======================================== ====================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
==== ======================================== ======================= ========================
GBP18.00 2,430.556
===================================================================== ========================
d) Aggregated information N/A (single transaction)
====
Aggregated volume
Price
================================================================== ===============================
e) Date of the transaction 2020-02-05
==== ======================================== ====================================================
f) Place of the N/A
transaction
==== ======================================== ====================================================
1. Details of PDMR/person closely associated with them
('PCA')
==== ==============================================================================================
a) Name Mr Vindi Banga
==== ======================================== ====================================================
b) Position/status Senior Independent Non-Executive Director
==== ======================================== ====================================================
c) Initial notification/ Initial notification
amendment
==== ======================================== ====================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
==== ==============================================================================================
a) Name GlaxoSmithKline plc
==== ======================================== ====================================================
b) LEI 5493000HZTVUYLO1D793
==== ======================================== ====================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
==== ==============================================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
==== ======================================== ====================================================
b) Nature of the Acquisition of notional Ordinary Shares
transaction under the share allocation arrangements
for Non-Executive Directors for the period
of service from 1 October 2019 to 31 December
2019
==== ======================================== ====================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
==== ======================================== ======================= ========================
GBP18.00 399.306
===================================================================== ========================
d) Aggregated information N/A (single transaction)
====
Aggregated volume
Price
================================================================== ===============================
e) Date of the transaction 2020-02-05
==== ======================================== ====================================================
f) Place of the N/A
transaction
==== ======================================== ====================================================
1. Details of PDMR/person closely associated with them
('PCA')
==== ==============================================================================================
a) Name Dr Vivienne Cox
==== ======================================== ====================================================
b) Position/status Independent Non-Executive Director
==== ======================================== ====================================================
c) Initial notification/ Initial notification
amendment
==== ======================================== ====================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
==== ==============================================================================================
a) Name GlaxoSmithKline plc
==== ======================================== ====================================================
b) LEI 5493000HZTVUYLO1D793
==== ======================================== ====================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
==== ==============================================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
==== ======================================== ====================================================
b) Nature of the Acquisition of notional Ordinary Shares
transaction under the share allocation arrangements
for Non-Executive Directors for the period
of service from 1 October 2019 to 31 December
2019
==== ======================================== ====================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
==== ======================================== ======================= ========================
GBP18.00 295.139
===================================================================== ========================
d) Aggregated information N/A (single transaction)
====
Aggregated volume
Price
================================================================== ===============================
e) Date of the transaction 2020-02-05
==== ======================================== ====================================================
f) Place of the N/A
transaction
==== ======================================== ====================================================
1. Details of PDMR/person closely associated with them
('PCA')
==== ===============================================================================================
a) Name Ms Lynn Elsenhans
==== ======================================== =====================================================
b) Position/status Independent Non-Executive Director
==== ======================================== =====================================================
c) Initial notification/ Initial notification
amendment
==== ======================================== =====================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
==== ===============================================================================================
a) Name GlaxoSmithKline plc
==== ======================================== =====================================================
b) LEI 5493000HZTVUYLO1D793
==== ======================================== =====================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
==== ===============================================================================================
a) Description of American Depositary Shares ('ADSs')
the financial ISIN: US37733W1053
instrument
==== ======================================== =====================================================
b) Nature of the Acquisition of notional ADSs under the
transaction share allocation arrangements for Non-Executive
Directors for the period of service from
1 October 2019 to 31 December 2019
==== ======================================== =====================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
==== ======================================== ======================= =========================
$46.88 1,055.371
======================= =========================
d) Aggregated information N/A (single transaction)
====
Aggregated volume
Price
========================================= =========================================================
e) Date of the transaction 2020-02-05
==== ======================================== =====================================================
f) Place of the N/A
transaction
==== ======================================== =====================================================
1. Details of PDMR/person closely associated with them
('PCA')
==== ===============================================================================================
a) Name Dr Laurie Glimcher
==== ======================================== =====================================================
b) Position/status Independent Non-Executive Director
==== ======================================== =====================================================
c) Initial notification/ Initial notification
amendment
==== ======================================== =====================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
==== ===============================================================================================
a) Name GlaxoSmithKline plc
==== ======================================== =====================================================
b) LEI 5493000HZTVUYLO1D793
==== ======================================== =====================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
==== ===============================================================================================
a) Description of American Depositary Shares ('ADSs')
the financial ISIN: US37733W1053
instrument
==== ======================================== =====================================================
b) Nature of the Acquisition of notional ADSs under the
transaction share allocation arrangements for Non-Executive
Directors for the period of service from
1 October 2019 to 31 December 2019
==== ======================================== =====================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
==== ======================================== ======================= =========================
$46.88 1,172.635
======================= =========================
d) Aggregated information N/A (single transaction)
====
Aggregated volume
Price
========================================= =========================================================
e) Date of the transaction 2020-02-05
==== ======================================== =====================================================
f) Place of the N/A
transaction
==== ======================================== =====================================================
1. Details of PDMR/person closely associated with them
('PCA')
==== ===============================================================================================
a) Name Dr Jesse Goodman
==== ======================================== =====================================================
b) Position/status Independent Non-Executive Director
==== ======================================== =====================================================
c) Initial notification/ Initial notification
amendment
==== ======================================== =====================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
==== ===============================================================================================
a) Name GlaxoSmithKline plc
==== ======================================== =====================================================
b) LEI 5493000HZTVUYLO1D793
==== ======================================== =====================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
==== ===============================================================================================
a) Description of American Depositary Shares ('ADSs')
the financial ISIN: US37733W1053
instrument
==== ======================================== =====================================================
b) Nature of the Acquisition of notional ADSs under the
transaction share allocation arrangements for Non-Executive
Directors for the period of service from
1 October 2019 to 31 December 2019
==== ======================================== =====================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
==== ======================================== ======================= =========================
$46.88 353.812
======================= =========================
d) Aggregated information N/A (single transaction)
====
Aggregated volume
Price
========================================= =========================================================
e) Date of the transaction 2020-02-05
==== ======================================== =====================================================
f) Place of the N/A
transaction
==== ======================================== =====================================================
1. Details of PDMR/person closely associated with them
('PCA')
==== ===============================================================================================
a) Name Ms Judy Lewent
==== ======================================== =====================================================
b) Position/status Independent Non-Executive Director
==== ======================================== =====================================================
c) Initial notification/ Initial notification
amendment
==== ======================================== =====================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
==== ===============================================================================================
a) Name GlaxoSmithKline plc
==== ======================================== =====================================================
b) LEI 5493000HZTVUYLO1D793
==== ======================================== =====================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
==== ===============================================================================================
a) Description of American Depositary Shares ('ADSs')
the financial ISIN: US37733W1053
instrument
==== ======================================== =====================================================
b) Nature of the Acquisition of notional ADSs under the
transaction share allocation arrangements for Non-Executive
Directors for the period of service from
1 October 2019 to 31 December 2019
==== ======================================== =====================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
==== ======================================== ======================= =========================
$46.88 394.248
======================= =========================
d) Aggregated information N/A (single transaction)
====
Aggregated volume
Price
========================================= =========================================================
e) Date of the transaction 2020-02-05
==== ======================================== =====================================================
f) Place of the N/A
transaction
==== ======================================== =====================================================
1. Details of PDMR/person closely associated with them
('PCA')
==== ==============================================================================================
a) Name Mr Urs Rohner
==== ======================================== ====================================================
b) Position/status Independent Non-Executive Director
==== ======================================== ====================================================
c) Initial notification/ Initial notification
amendment
==== ======================================== ====================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
==== ==============================================================================================
a) Name GlaxoSmithKline plc
==== ======================================== ====================================================
b) LEI 5493000HZTVUYLO1D793
==== ======================================== ====================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
==== ==============================================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
==== ======================================== ====================================================
b) Nature of the Acquisition of notional Ordinary Shares
transaction under the share allocation arrangements
for Non-Executive Directors for the period
of service from 1 October 2019 to 31 December
2019
==== ======================================== ====================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
==== ======================================== ======================= ========================
GBP18.00 399.306
===================================================================== ========================
d) Aggregated information N/A (single transaction)
====
Aggregated volume
Price
================================================================== ===============================
e) Date of the transaction 2020-02-05
==== ======================================== ====================================================
f) Place of the N/A
transaction
==== ======================================== ====================================================
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
DSHQELFBBLLBBBQ
(END) Dow Jones Newswires
February 05, 2020 11:15 ET (16:15 GMT)
Grafico Azioni Gsk (LSE:GSK)
Storico
Da Mar 2024 a Apr 2024
Grafico Azioni Gsk (LSE:GSK)
Storico
Da Apr 2023 a Apr 2024
